130 related articles for article (PubMed ID: 25881846)
1. Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis.
Medina-Arana V; Martínez-Riera A; Delgado-Plasencia L; Rodríguez-González D; Bravo-Gutiérrez A; Álvarez-Argüelles H; Alarcó-Hernández A; Salido-Ruiz E; Fernández-Peralta AM; González-Aguilera JJ
Medicine (Baltimore); 2015 Apr; 94(15):e703. PubMed ID: 25881846
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis.
Kang SM; Maeda K; Onoda N; Chung YS; Nakata B; Nishiguchi Y; Sowa M
Int J Cancer; 1997 Oct; 74(5):502-7. PubMed ID: 9355971
[TBL] [Abstract][Full Text] [Related]
3. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.
Chen HS; Sheen-Chen SM
Surgery; 2000 Apr; 127(4):370-6. PubMed ID: 10776426
[TBL] [Abstract][Full Text] [Related]
4. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
5. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer: Greater neo-angiogenesis, less perforation, worst oncological outcomes.
Fransvea P; Costa G; Sganga G
Med Hypotheses; 2021 Jan; 146():110458. PubMed ID: 33341528
[TBL] [Abstract][Full Text] [Related]
7. The survival rate and prognostic factors in 26 perforated colorectal cancer patients.
Lee IK; Sung NY; Lee YS; Lee SC; Kang WK; Cho HM; Ahn CH; Lee DS; Oh ST; Kim JG; Jeon HM; Chang SK
Int J Colorectal Dis; 2007 May; 22(5):467-73. PubMed ID: 16947042
[TBL] [Abstract][Full Text] [Related]
8. Metastatic lymphs nodes and lymph node ratio as predictive factors of survival in perforated and non-perforated T4 colorectal tumors.
Rodríguez-González D; Martínez-Riera A; Delgado-Plasencia L; Bravo-Gutiérrez A; Alvarez-Argüelles H; Salido E; Fernández-Peralta AM; González-Aguilera JJ; Alarcó-Hernández A; Medina-Arana V
J Surg Oncol; 2013 Sep; 108(3):176-81. PubMed ID: 23832524
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.
Xiong B; Sun TJ; Yuan HY; Hu MB; Hu WD; Cheng FL
World J Gastroenterol; 2003 Jun; 9(6):1237-40. PubMed ID: 12800231
[TBL] [Abstract][Full Text] [Related]
10. [Study of angiogenesis in human colorectal carcinoma and its modulation by p53 and K-ras gene].
Zhong SS; Zhang ZS; Li SM; Deng HJ; Ma Q
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):77-80. PubMed ID: 12783699
[TBL] [Abstract][Full Text] [Related]
11. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
12. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
[TBL] [Abstract][Full Text] [Related]
13. p73 Overexpression and angiogenesis in human colorectal carcinoma.
Guan M; Peng HX; Yu B; Lu Y
Jpn J Clin Oncol; 2003 May; 33(5):215-20. PubMed ID: 12865464
[TBL] [Abstract][Full Text] [Related]
14. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
[TBL] [Abstract][Full Text] [Related]
15. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
16. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
18. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
19. TGF beta1 expression and angiogenesis in colorectal cancer tissue.
Xiong B; Gong LL; Zhang F; Hu MB; Yuan HY
World J Gastroenterol; 2002 Jun; 8(3):496-8. PubMed ID: 12046078
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for the recurrence of stage II perforated colorectal cancer: A retrospective observational study.
Asano H; Fukano H; Takagi M; Takayama T
Asian J Surg; 2023 Jan; 46(1):201-206. PubMed ID: 35331590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]